A randomized controlled trial of heterologous ChAdOx1 nCoV-19 and recombinant subunit vaccine MVC-COV1901 against COVID-19

Journal

Nature Communications

Journal Volume

13

Journal Issue

1

Date Issued

2022

Author(s)

Chen C.-J.

Yang L.-Y.

Chang W.-Y.

Huang Y.-C.

Chiu C.-H.

Shih S.-R.

Huang C.-G.

Kuan-Ying A. Huang

DOI

10.1038/s41467-022-33146-7

URI

https://www.scopus.com/inward/record.uri?eid=2-s2.0-85138146832&doi=10.1038%2fs41467-022-33146-7&partnerID=40&md5=d7848cf918c2c660c17037ab208542d5

https://scholars.lib.ntu.edu.tw/handle/123456789/627125

SDGs

[SDGs]SDG3

Publisher

Nature Research

Type

journal article